Search Results
CTAC Talks! Eliminating hepatitis C in Canada
CTAC TALKS: HEPATITIS C IN CANADA- PREVALENCE, TREATMENT & ACCESSIBILITY TO DRUGS
CTAC Talks! International Targets: Reaching 90-90-90 and eliminating HCV
HCV treatment in federal institutions
CTAC Patient Group Input Webinar: MK2 (Elbasvir/Grazoprevir)
CTAC PGI webinar: Ombitasvir/Paritaprevir/ritonavir
Queuing and the PCPA: Current Issues in Hepatitis C
CTAC Patient Group Input Consultation: Glecaprevir Pibrentasvir
Blueprint to inform hepatitis C elimination efforts in Canada launch session
CTAC: Patient Input Consultation Webinar on Simeprevir (August 29, 2013)
Dr. Jordan Feld: Hepatitis C screening in Canada
CTAC Talks Ep. 3 (Canadian Association For HIV Research)
